| Paradoxical roles of the immune system during cancer development KE De Visser, A Eichten, LM Coussens Nature reviews cancer 6 (1), 24-37, 2006 | 2965 | 2006 |
| IL-17-producing gdT cells and neutrophils conspire to promote breast cancer metastasis SB Coffelt, K Kersten, CW Doornebal, J Weiden, K Vrijland, CS Hau, ... Nature, 2015 | 1759 | 2015 |
| Neutrophils in cancer: neutral no more SB Coffelt, MD Wellenstein, KE de Visser Nature Reviews Cancer 16 (7), 431-446, 2016 | 1735 | 2016 |
| The evolving tumor microenvironment: From cancer initiation to metastatic outgrowth KE de Visser, JA Joyce Cancer Cell 41 (3), 374-403, 2023 | 1458 | 2023 |
| Targeting tumor-associated macrophages with anti-CSF-1R antibody reveals a strategy for cancer therapy CH Ries, MA Cannarile, S Hoves, J Benz, K Wartha, V Runza, ... Cancer cell 25 (6), 846-859, 2014 | 1415 | 2014 |
| De novo carcinogenesis promoted by chronic inflammation is B lymphocyte dependent KE de Visser, LV Korets, LM Coussens Cancer cell 7 (5), 411-423, 2005 | 989 | 2005 |
| Immune induction strategies in metastatic triple-negative breast cancer to enhance the sensitivity to PD-1 blockade: the TONIC trial L Voorwerk, M Slagter, HM Horlings, K Sikorska, KK van de Vijver, ... Nature medicine 25 (6), 920-928, 2019 | 819 | 2019 |
| FcRγ activation regulates inflammation-associated squamous carcinogenesis P Andreu, M Johansson, NI Affara, F Pucci, T Tan, S Junankar, L Korets, ... Cancer cell 17 (2), 121-134, 2010 | 652 | 2010 |
| Cancer-cell-intrinsic mechanisms shaping the tumor immune landscape MD Wellenstein, KE de Visser Immunity 48 (3), 399-416, 2018 | 605 | 2018 |
| Genetically engineered mouse models in oncology research and cancer medicine K Kersten, KE de Visser, MH van Miltenburg, J Jonkers EMBO molecular medicine 9 (2), 137-153, 2017 | 519 | 2017 |
| Chimeric papillomavirus virus-like particles elicit antitumor immunity against the E7 oncoprotein in an HPV16 tumor model HL Greenstone, JD Nieland, KE De Visser, MLH De Bruijn, R Kirnbauer, ... Proceedings of the National Academy of Sciences 95 (4), 1800-1805, 1998 | 473 | 1998 |
| Loss of p53 triggers WNT-dependent systemic inflammation to drive breast cancer metastasis MD Wellenstein, SB Coffelt, DEM Duits, MH van Miltenburg, M Slagter, ... Nature 572 (7770), 538-542, 2019 | 455 | 2019 |
| Immune crosstalk in cancer progression and metastatic spread: a complex conversation H Garner, KE de Visser Nature Reviews Immunology 20 (8), 483-497, 2020 | 373 | 2020 |
| Selective induction of chemotherapy resistance of mammary tumors in a conditional mouse model for hereditary breast cancer S Rottenberg, AOH Nygren, M Pajic, FWB van Leeuwen, ... Proceedings of the National Academy of Sciences 104 (29), 12117-12122, 2007 | 371 | 2007 |
| The inflammatory tumor microenvironment and its impact on cancer development K de Visser, L Coussens Infection and Inflammation: Impacts on Oncogenesis 13, 118-137, 2006 | 300 | 2006 |
| Inflammation, proteases and cancer LCL van Kempen, KE de Visser, LM Coussens European journal of cancer 42 (6), 728-734, 2006 | 237 | 2006 |
| Effects of TGF-β on the immune system: implications for cancer immunotherapy KE De Visser, WM Kast Leukemia 13 (8), 1188-1199, 1999 | 234 | 1999 |
| Neutrophil phenotypes and functions in cancer: A consensus statement DF Quail, B Amulic, M Aziz, BJ Barnes, E Eruslanov, ZG Fridlender, ... Journal of Experimental Medicine 219 (6), e20220011, 2022 | 223 | 2022 |
| Developmental stage‐specific contribution of LGR5+ cells to basal and luminal epithelial lineages in the postnatal mammary gland KE de Visser, M Ciampricotti, E Michalak, D Wei‐Min Tan, EN Speksnijder, ... The Journal of Pathology, 2012 | 205 | 2012 |
| Therapeutic targeting of macrophages enhances chemotherapy efficacy by unleashing type I interferon response C Salvagno, M Ciampricotti, S Tuit, CS Hau, A van Weverwijk, SB Coffelt, ... Nature cell biology 21 (4), 511-521, 2019 | 167 | 2019 |
